-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on GeneDx Holdings, Lowers Price Target to $100

Benzinga·03/30/2026 14:57:05
Listen to the news
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $100.